Bremer Trust National Association’s Editas Medicine EDIT Stock Holding History

Bremer Trust National Association’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2K	Buy	+100	New	+$2.72K	﹤0.01%	734

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bremer Trust National Association's EDIT Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Editas Medicine (EDIT) in Q4 2018: 100 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings.

194 funds tracked by Wall St. Rank hold EDIT as of Q4 2018.

Bremer Trust National Association held 100 shares of Editas Medicine worth $2K as of Q4 2018.
Editas Medicine was a new Bremer Trust National Association position in Q4 2018.
Editas Medicine made up ﹤0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #734 holding.
194 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.